Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) traded down 5.6% during trading on Monday. The stock traded as low as $35.10 and last traded at $34.6860. 128,435 shares traded hands during trading, a decline of 71% from the average session volume of 438,700 shares. The stock had previously closed at $36.75.
Wall Street Analysts Forecast Growth
TRUP has been the subject of a number of analyst reports. Wall Street Zen raised shares of Trupanion from a “hold” rating to a “buy” rating in a report on Saturday. Weiss Ratings upgraded shares of Trupanion from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, September 29th. Piper Sandler cut shares of Trupanion from an “overweight” rating to a “neutral” rating and dropped their price target for the company from $45.00 to $32.00 in a research note on Wednesday, August 26th. Cantor Fitzgerald raised their price target on shares of Trupanion from $30.00 to $33.00 and gave the stock a “neutral” rating in a report on Monday. Finally, Stifel Nicolaus lifted their price target on shares of Trupanion from $29.00 to $34.00 and gave the company a “hold” rating in a research report on Monday. One investment analyst has rated the stock with a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, Trupanion currently has a consensus rating of “Hold” and a consensus target price of $40.00.
Read Our Latest Report on Trupanion
Trupanion Stock Performance
The stock has a market capitalization of $1.52 billion, a PE ratio of 57.58, a price-to-earnings-growth ratio of 2.16 and a beta of 1.27. The firm’s fifty day moving average is $27.14 and its 200-day moving average is $26.69. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.24.
Trupanion (NASDAQ:TRUP – Get Free Report) last announced its earnings results on Thursday, November 5th. The financial services provider reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.05. Trupanion had a net margin of 1.71% and a return on equity of 6.71%. The company had revenue of $405.59 million during the quarter, compared to analyst estimates of $402.53 million. During the same quarter last year, the firm posted $0.13 earnings per share. As a group, research analysts anticipate that Trupanion, Inc. will post 0.64 earnings per share for the current year.
Insider Buying and Selling
In related news, COO John Gallagher sold 3,604 shares of Trupanion stock in a transaction that occurred on Friday, August 28th. The shares were sold at an average price of $29.70, for a total value of $107,038.80. Following the completion of the sale, the chief operating officer owned 33,742 shares in the company, valued at approximately $1,002,137.40. This trade represents a 9.65% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Margaret Tooth sold 1,000 shares of the business’s stock in a transaction that occurred on Friday, October 9th. The shares were sold at an average price of $25.84, for a total value of $25,840.00. Following the completion of the sale, the chief executive officer directly owned 184,952 shares in the company, valued at approximately $4,779,159.68. The trade was a 0.54% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 14,046 shares of company stock valued at $407,743. Company insiders own 5.58% of the company’s stock.
Hedge Funds Weigh In On Trupanion
A number of hedge funds and other institutional investors have recently bought and sold shares of the company. Bank of New York Mellon Corp acquired a new position in Trupanion in the 2nd quarter valued at about $4,631,000. Bank of America Corp DE acquired a new stake in shares of Trupanion during the second quarter worth about $14,262,000. Renaissancere Holdings Ltd. acquired a new stake in shares of Trupanion during the second quarter worth about $6,514,510. Legal & General Group Plc purchased a new position in shares of Trupanion in the second quarter valued at approximately $1,938,000. Finally, GSA Capital Partners LLP purchased a new position in shares of Trupanion in the second quarter valued at approximately $1,394,000.
Trupanion Company Profile
Trupanion, Inc is a pet insurance company that provides medical insurance coverage for cats and dogs. Its products are designed to help pet owners manage the cost of veterinary care, including coverage for eligible illnesses, injuries and other qualifying medical conditions, subject to the terms of each policy.
The company offers subscription-based pet insurance through the Trupanion brand, with coverage generally intended for ongoing veterinary expenses rather than routine or preventive care.
Read More
- Five stocks we like better than Trupanion
- Want to Escape the AI Sell-Off? This ETF Offers a Surprising Alternative
- America’s Rare Earth Clock Is Running Out, But the Bottleneck Isn’t Where You Think
- Atlassian Tanks After Huge Run as Guidance Disappoints, But Strength Remains
- Lemonade’s Revenue Soars 73%—So Why Did Its Stock Turn Sour After Earnings?
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
